Matches in Wikidata for { <http://www.wikidata.org/entity/Q79976029> ?p ?o ?g. }
- Q79976029 description "2006 nî lūn-bûn" @default.
- Q79976029 description "2006年の論文" @default.
- Q79976029 description "2006年学术文章" @default.
- Q79976029 description "2006年学术文章" @default.
- Q79976029 description "2006年学术文章" @default.
- Q79976029 description "2006年学术文章" @default.
- Q79976029 description "2006年学术文章" @default.
- Q79976029 description "2006年学术文章" @default.
- Q79976029 description "2006年學術文章" @default.
- Q79976029 description "2006年學術文章" @default.
- Q79976029 description "2006年學術文章" @default.
- Q79976029 description "2006年學術文章" @default.
- Q79976029 description "2006年學術文章" @default.
- Q79976029 description "2006년 논문" @default.
- Q79976029 description "article científic" @default.
- Q79976029 description "article scientific" @default.
- Q79976029 description "article scientifique" @default.
- Q79976029 description "articol științific" @default.
- Q79976029 description "articolo scientifico" @default.
- Q79976029 description "artigo científico" @default.
- Q79976029 description "artigo científico" @default.
- Q79976029 description "artigo científico" @default.
- Q79976029 description "artikel ilmiah" @default.
- Q79976029 description "artikull shkencor" @default.
- Q79976029 description "artikulong pang-agham" @default.
- Q79976029 description "artykuł naukowy" @default.
- Q79976029 description "artículo científico publicado en 2006" @default.
- Q79976029 description "artículu científicu" @default.
- Q79976029 description "bilimsel makale" @default.
- Q79976029 description "bài báo khoa học" @default.
- Q79976029 description "naučni članak" @default.
- Q79976029 description "scienca artikolo" @default.
- Q79976029 description "scientific article published on 24 July 2006" @default.
- Q79976029 description "scientific article published on 24 July 2006" @default.
- Q79976029 description "scientific article published on 24 July 2006" @default.
- Q79976029 description "teaduslik artikkel" @default.
- Q79976029 description "tieteellinen artikkeli" @default.
- Q79976029 description "tudományos cikk" @default.
- Q79976029 description "vedecký článok" @default.
- Q79976029 description "vetenskaplig artikel" @default.
- Q79976029 description "videnskabelig artikel udgivet 24. juli 2006" @default.
- Q79976029 description "vitenskapelig artikkel" @default.
- Q79976029 description "vitskapeleg artikkel" @default.
- Q79976029 description "vědecký článek" @default.
- Q79976029 description "wetenschappelijk artikel" @default.
- Q79976029 description "wissenschaftlicher Artikel" @default.
- Q79976029 description "επιστημονικό άρθρο" @default.
- Q79976029 description "мақолаи илмӣ" @default.
- Q79976029 description "наукова стаття, опублікована в липні 2006" @default.
- Q79976029 description "научна статия" @default.
- Q79976029 description "научная статья" @default.
- Q79976029 description "научни чланак" @default.
- Q79976029 description "научни чланак" @default.
- Q79976029 description "מאמר מדעי" @default.
- Q79976029 description "مقالة علمية نشرت في 24 يوليو 2006" @default.
- Q79976029 description "২৪ জুলাই ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q79976029 description "บทความทางวิทยาศาสตร์" @default.
- Q79976029 description "სამეცნიერო სტატია" @default.
- Q79976029 name "Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma" @default.
- Q79976029 name "Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma" @default.
- Q79976029 type Item @default.
- Q79976029 label "Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma" @default.
- Q79976029 label "Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma" @default.
- Q79976029 prefLabel "Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma" @default.
- Q79976029 prefLabel "Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma" @default.
- Q79976029 P1433 Q79976029-736FE05C-8F56-4584-93DE-C2F8BB9AE242 @default.
- Q79976029 P1476 Q79976029-6251EC9D-BA92-4816-9622-E368614C3815 @default.
- Q79976029 P2093 Q79976029-00BED886-EB5E-4596-9B12-D61B3ADE0A20 @default.
- Q79976029 P2093 Q79976029-1F08F413-E91F-4CC2-A184-3DC92C00A3DD @default.
- Q79976029 P2093 Q79976029-2FE678AC-94E2-427F-BC87-23620C630CDB @default.
- Q79976029 P2093 Q79976029-7265A07F-DE71-4750-A04B-6E190BEA8B84 @default.
- Q79976029 P2093 Q79976029-732F49C0-3517-4865-A252-20DA8855E0CC @default.
- Q79976029 P2093 Q79976029-819DCB51-FEBC-4D12-A520-C2066AE2F49C @default.
- Q79976029 P2093 Q79976029-A4F89608-3880-4E3B-9B8C-D746DB5A4DBC @default.
- Q79976029 P2093 Q79976029-C55DC023-0401-480C-B5BD-F30ED44EFE3E @default.
- Q79976029 P2093 Q79976029-CC7D972E-0D43-41EA-98BE-CE27849D9697 @default.
- Q79976029 P2093 Q79976029-E6CE527F-E7D8-42F6-A4EE-1B37B658BC80 @default.
- Q79976029 P2093 Q79976029-F47D8DD0-4882-4B3A-A678-690852203A83 @default.
- Q79976029 P2093 Q79976029-F4C62720-B983-4A75-932A-EBAD8116D394 @default.
- Q79976029 P304 Q79976029-737C471F-6370-48D5-B941-1A5A49DC3EC6 @default.
- Q79976029 P31 Q79976029-F6FBBD85-E345-4C30-86CE-534B0D8B2F9B @default.
- Q79976029 P356 Q79976029-CAE68DC2-8906-4367-9B4D-E97DA38AE6A1 @default.
- Q79976029 P433 Q79976029-D1633D50-3575-4CFC-93C2-5F53C9192A00 @default.
- Q79976029 P478 Q79976029-642D799B-EAC5-4788-B3C2-A6847C5546E2 @default.
- Q79976029 P50 Q79976029-ED05D323-600C-4A9D-A0A7-C6DDA7B11124 @default.
- Q79976029 P577 Q79976029-2ECB37CF-AAC5-4752-99E6-C88A019A2474 @default.
- Q79976029 P698 Q79976029-8B89C344-A6B4-4BF7-B013-DE85859DE8ED @default.
- Q79976029 P921 Q79976029-1F2EDBCF-A4B4-423C-944D-61209AE308BC @default.
- Q79976029 P921 Q79976029-2C4D0DDA-0C01-47EC-9C96-B53E9C19433F @default.
- Q79976029 P921 Q79976029-4A36D6C2-3B6A-49BA-99FD-0F481A19C620 @default.
- Q79976029 P921 Q79976029-E636958C-EA69-4999-A660-45FAEED9E8FB @default.
- Q79976029 P356 JCO.2006.05.6291 @default.
- Q79976029 P698 16864854 @default.
- Q79976029 P1433 Q400292 @default.
- Q79976029 P1476 "Multicenter phase II trial of immunotherapy with the humanized anti-CD22 antibody, epratuzumab, in combination with rituximab, in refractory or recurrent non-Hodgkin's lymphoma" @default.
- Q79976029 P2093 "Andreas Engert" @default.
- Q79976029 P2093 "Bernard Coiffier" @default.
- Q79976029 P2093 "David M Goldenberg" @default.
- Q79976029 P2093 "Dieter F Hoelzer" @default.
- Q79976029 P2093 "Frank Morschhauser" @default.